"Dr. Jeffrey Alper, your Naples Arthritis Doctor, and his rheumatologist staff are committed to providing comprehensive and high-quality rheumatology care for adults. We work with our patients to accurately diagnose and effectively treat rheumatic diseases in a professional and caring environment.Our only focus is on treating patients with rheumatic diseases such as rheumatoid arthritis and arthritis pain."

During the past decade, Jeffrey Alper MD Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 9 clinical trials were completed, i.e. on average, 180% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jeffrey Alper MD Research" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jeffrey Alper MD Research" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Jeffrey Alper MD Research" are "Rheumatoid Arthritis" (5 trials), "Arthritis, Rheumatoid" (2 trials), "Psoriatic Arthritis" (2 trials), "Arthritis" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Jeffrey Alper MD Research" in a lesser frequency.

Most popular intervention types in "Jeffrey Alper MD Research" are "Drug" (10 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Apremilast 30 mg" (2 trials), "CP-690,550" (2 trials), "Apremilast 20 mg" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jeffrey Alper MD Research" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Jeffrey Alper MD Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Jeffrey Alper MD Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Jeffrey Alper MD Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".